A.RippertP.JabrinS.CurienG.RbeillF.et al (2004)
If youve started a GLP-1 medication and your digestion has changed, speak to your doctor about the symptoms
This applies, for instance, to secretin, which quite powerfully stimulates glucose-induced insulin secretion, but when infused in healthy volunteers reaching postprandial concentrations, it failed to do so (9)
MeAgain is built by people who deeply understand that journey
Instead, filed lawsuits involving GLP-1 medications have been consolidated into two separate multidistrict litigations (MDLs) in federal court: one involving gastrointestinal injuries such as gastroparesis and bowel obstruction, and another involving vision loss claims associated with non-arteritic anterior ischemic optic neuropathy (NAION)
Del Prato S, Kang J, Trautmann ME et al (2020) Efficacy and safety of once-monthly efpeglenatide in patients with type 2 diabetes: results of a phase 2 placebo-controlled, 16-week randomized dose-finding study
